Another step closer to a COVID-19 vaccine for babies and toddlers came after Australian authorities confirmed that they are evaluating a low dose of Moderna’s Spikevax.
There are no COVID-19 vaccines licensed for babies under four years old at this time.
Pfizer’s vaccine is approved for use in children five and older, while Moderna Australia is seeking approval to extend Spikevax to children under six years old.
The TGA has confirmed that it is evaluating using a low dose of Spikevax, 25 micrograms in 0.25ml, for children aged six months to five years old.
The current 50 micrograms in 0.25ml method is being used for youngsters aged six to 11 years old.
Spikevax, a mRNA vaccine, employs a genetic code to generate the coronavirus spike protein.